Skip to main content
Cell Death & Disease logoLink to Cell Death & Disease
. 2014 Aug 28;5(8):e1388. doi: 10.1038/cddis.2014.340

A new platinum(II) compound anticancer drug candidate with selective cytotoxicity for breast cancer cells

A Muscella, C Vetrugno, F P Fanizzi, C Manca, S A De Pascali, S Marsigliante
PMCID: PMC4454315

Correction to: Cell Death and Disease (2013) 4, e796; doi:10.1038/cddis.2013.315; published online 12 September 2013

Since the publication of this paper the authors have noticed a number of errors. On page 1, second paragraph, the first sentence should read:

In this context, new Pt(II) complexes have been specifically synthesized by some of us in order to overcome the cisplatin-related problems.2,3 The ability of these new Pt(II) compounds to induce apoptosis in human cancer cells has been studied and compared with the well-established anticancer drug, cisPt; among them, [Pt(O,O′-acac)(γ-acac)(DMS)] (PtAcD) exhibited the highest in vitro activity.

On page 9, second column, the starting sentence under ‘Reagents' should read:

Reagents

PtAcD was prepared according to previously reported procedures.3

Reference 2 has been removed and replaced by the original reference 33.

The corrected article appears online together with this corrigendum. The authors would like to apologize for any inconvenience this may have caused.


Articles from Cell Death & Disease are provided here courtesy of Nature Publishing Group

RESOURCES